While adopting new technology is obviously a big part of healthcare innovation teams' work, there are plenty of worthwhile initiatives that don't involve advanced technologies, pointed out Dan Shoenthal, chief innovation officer at MD Anderson Cancer Center.
Time is running out! Don't let this chance slip away – register now for INVEST 2024, happening next week, May 21-22 in Chicago.
Experience unmatched networking and be a part of shaping the future of healthcare investment at this premier event in the Windy City. Act today, and secure your place at INVEST 2024 before it's too late!
The dangers of polypharmacy and its increasingly wide reach across the American population make it imperative that we enhance the accuracy and efficiency of medication reconciliation processes.
Johnson & Johnson's Proteologix acquisition adds a pipeline of bispecific antibodies, including an experimental treatment for asthma and atopic dermatitis. It's the latest M&A deal involving molecules addressing TSLP, a key signaling protein involved in inflammation.
Season 2 of the MedCity Pivot Podcast has launched with a special focus on the evolution of pharmacy and pharmacy benefit management. The first guest this season is A.J. Loiacono, who leads Capital Rx.
No comments